Abivax (ABVX) Intangibles (2021 - 2026)
Abivax (ABVX) posted quarterly Intangibles of $7.7 million for Q1 2026, up 11.28% year-over-year from $6.9 million in Q1 2025, and up 0.58% quarter-over-quarter from $7.7 million in Q4 2025.
Abivax (ABVX) Intangibles (2021 - 2026) Analysis & Trends
Abivax's Intangibles history runs 6 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Intangibles rose 11.28% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (up 11.28% YoY), while the FY2025 annual figure was $7.7 million, up 8.92% from the prior year.
- Intangibles for Q1 2026 stood at $7.7 million, up from $7.7 million in the prior quarter.
- The five-year high for Intangibles was $7.7 million in Q1 2026, with the low at $6.7 million in Q4 2022.
- The 5-year median for Intangibles is $7.1 million (2024), against an average of $7.3 million.
- The sharpest annual moves came in 2022 and 2024: Intangibles soared 6235.95% in 2022, then declined 0.65% in 2024.
- Abivax's Intangibles stood at $6.7 million in 2022, then rose by 5.41% to $7.1 million in 2023, then slipped by 0.65% to $7.1 million in 2024, then advanced by 8.92% to $7.7 million in 2025, then increased by 0.58% to $7.7 million in 2026.
- Business Quant data shows ABVX's Intangibles at $7.7 million in Q1 2026, $7.7 million in Q4 2025, and $7.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | 7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.73 Mn |
| Dec 31, 2025 | 7.69 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 6.95 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Jun 30, 2024 | 7.11 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Dec 31, 2022 | 6.74 Mn |
| Dec 31, 2021 | 106,389.30 |